A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.
- Published In:
- Neuropharmacology, 117, 238-248 (2017)
- Database ID:
- RPEP-03332
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03332APA
Jalewa, Jaishree; Sharma, Mohit Kumar; Gengler, Simon; Hölscher, Christian. (2017). A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.. Neuropharmacology, 117, 238-248. https://doi.org/10.1016/j.neuropharm.2017.02.013
MLA
Jalewa, Jaishree, et al. "A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.." Neuropharmacology, 2017. https://doi.org/10.1016/j.neuropharm.2017.02.013
RethinkPeptides
RethinkPeptides Research Database. "A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA..." RPEP-03332. Retrieved from https://rethinkpeptides.com/research/jalewa-2017-a-novel-glp1gip-dual
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.